Creative Planning Buys 27,109 Shares of Relx Plc $RELX

Creative Planning increased its stake in Relx Plc (NYSE:RELX) by 14.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 214,293 shares of the technology company’s stock after buying an additional 27,109 shares during the quarter. Creative Planning’s holdings in Relx were worth $11,645,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of RELX. Goldman Sachs Group Inc. raised its stake in shares of Relx by 4.5% in the first quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company’s stock valued at $205,287,000 after acquiring an additional 173,976 shares during the period. Ameriprise Financial Inc. grew its holdings in Relx by 8.3% during the 1st quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock valued at $154,129,000 after purchasing an additional 234,094 shares during the last quarter. Northern Trust Corp raised its position in Relx by 9.2% in the 1st quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after purchasing an additional 202,509 shares during the period. Natixis Advisors LLC raised its position in Relx by 0.5% in the 1st quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company’s stock worth $60,919,000 after purchasing an additional 5,875 shares during the period. Finally, ABC Arbitrage SA lifted its stake in Relx by 188.9% in the second quarter. ABC Arbitrage SA now owns 560,958 shares of the technology company’s stock worth $30,482,000 after purchasing an additional 366,761 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on RELX. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Relx in a research note on Thursday, November 13th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Barclays reiterated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Finally, Wall Street Zen downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Relx Trading Down 0.3%

Shares of NYSE RELX opened at $40.27 on Wednesday. Relx Plc has a 52-week low of $40.00 and a 52-week high of $56.33. The stock has a 50 day moving average price of $45.21 and a 200 day moving average price of $49.52. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.